Kaneko M, Sakata Y, Matsuda M, Mimuro J
Division of Hemostasis and Thrombosis Research, Jichi Medical School, Tochigi.
J Biochem. 1992 Feb;111(2):244-8. doi: 10.1093/oxfordjournals.jbchem.a123744.
We have shown that plasminogen activator inhibitor-1 (PAI-1) inhibits the fibrin binding of both the single chain and two chain forms of tissue-type plasminogen activator (tPA) through two different mechanisms. PAI-1 inhibits the finger domain-dependent fibrin binding of diisopropylfluorophosphate-inactivated single chain tPA and the kringle-2 domain-dependent fibrin binding of diisopropylfluorophosphate-inactivated two chain tPA. In accordance with the data, preformed complexes of single chain tPA/PAI-1 and of two chain tPA/PAI-1 lost the fibrin binding abilities mediated by the finger and kringle-2 domains, respectively. These effects of PAI-1 appear to be mediated by steric hindrance of the fibrin binding sites after PAI-1 binding to adjacent regions in the functional domains of tPA. We thus propose a model in which a PAI-1 binding site resides in the finger domain of a single chain, and plays a role in the reversible association of single chain tPA and PAI-1. Conformational changes may take place during the conversion of single chain tPA to two chain tPA, resulting in burying of the original PAI-1 binding site and exposure of an alternate PAI-1 binding site on the surface of the kringle-2 domain.
我们已经证明,纤溶酶原激活物抑制剂-1(PAI-1)通过两种不同机制抑制组织型纤溶酶原激活物(tPA)单链和双链形式与纤维蛋白的结合。PAI-1抑制二异丙基氟磷酸酯灭活的单链tPA的指状结构域依赖性纤维蛋白结合以及二异丙基氟磷酸酯灭活的双链tPA的kringle-2结构域依赖性纤维蛋白结合。根据这些数据,单链tPA/PAI-1和双链tPA/PAI-1的预形成复合物分别丧失了由指状结构域和kringle-2结构域介导的纤维蛋白结合能力。PAI-1的这些作用似乎是由PAI-1与tPA功能结构域中相邻区域结合后对纤维蛋白结合位点的空间位阻介导的。因此,我们提出一个模型,其中PAI-1结合位点位于单链的指状结构域中,并在单链tPA和PAI-1的可逆缔合中起作用。在单链tPA转化为双链tPA的过程中可能发生构象变化,导致原始PAI-1结合位点被掩埋,kringle-2结构域表面的另一个PAI-1结合位点暴露。